Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
IN8bio
Watchlist
INAB: 1Q:24 Results
Equity Bottom-Up
314 Views
20 May 2024 14:00
Issuer-paid
IN8Bio is a clinical-stage, oncology-focused biotechnology company using ?d T cells against solid and hematological tumors. Its pipeline is built...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »
INAB: Introducing INB-600, A ?d T Cell Engager Platform
INAB: Continued Survival in INB-100 Trial
INAB: Upcoming Presentations at SNO & ASH
INAB: Restructuring Narrows Focus to AML
INAB: AML & GBM Clinical Update
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Event-Driven
Sell / Short Ideas
Asia Event-Driven
Japan
South Korea
India
Unpaywalled Insights
Philippines
Trending Insights
More »
Dian Swastatika Sentosa (DSSA IJ): Surprise, Surprise!
Korea Local Banks: New Dividend Tax Effectively Locks in a De Facto Minimum Yield Play
Intel. Crisis Mode All Over Again
Iress (IRE AU): Nothing Firm As Blackstone And Thoma Bravo Circle
PG Electroplast: KMP Selling and Lowering Guidance
Top Unpaywalled Insights
More »
[IO Technicals 2025/32] Bullish Momentum Builds
Grab Holdings (GRAB US) - Harvesting Sequentially
Micro-Mechanics (Holdings) Limited - Next Generation Supplier of the Semicon Industry
Bond Market Monitor: Thai Corporations UnSmiled
Rising Ringgit, Eroding Fundamentals
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
INAB: 1Q:24 Results
20 May 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x